1.25mg tirzepatide Compounded Microdose Tirzepatide Injectable – 25 mg/mL

PlexusDx providers coordinate with your primary care physician to adjust concomitant medications and monitor for hypotension as weight loss accelerates

GLP-1 receptor agonists such as Saxenda and Wegovy work, with clinical trial evidence behind them roughly 6% and 16% body weight reduction respectively over 68-week trials

While using a medication from each class in combination does not pose a safety concern for patients, there is no evidence supporting additive efficacy with this combination

Effect of a Topical Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin: A Pilot Study

More offers

Body Weight and Composition Your current body weight and composition are crucial determinants in establishing the right semaglutide dosage